ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Animal Health Active Pharmaceutical Ingredients Market Analysis 2021-2026 by Business, Indication, Synthesis, Type, End-User, Geography, Competitive Analysis - ResearchAndMarkets.com

August 23, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Aug 23, 2021--

The “Global Animal Health Active Pharmaceutical Ingredients Market (2021-2026) by Business, Indication, Synthesis, Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Animal Health Active Pharmaceutical Ingredients Market is estimated to be USD 16.12 Bn in 2021 and is expected to reach USD 23.63 Bn by 2026, growing at a CAGR of 7.95%.

ADVERTISEMENT

Market Dynamics

The global animal health active pharmaceutical ingredients market is being driven by increasing animal healthcare infrastructure and facilities, rising focus on animal well-being, an increase in the number of animal healthcare NGOs, increased pet adoption, and unmet medical needs.

In addition, as the economies are growing, more governments and pharmaceutical firms are investing in animal healthcare, and the rising research and development activities and the growing focus on innovations are projected to offer lucrative growth opportunities for the growth of global animal health active pharmaceutical ingredients market.

However, the market’s development is being restrained by rising costs and the Government’s regulatory prohibitions on the animal pharmaceuticals industry.

Market Segmentation

ADVERTISEMENT

  • The Global Animal Health Active Pharmaceutical Ingredients Market is segmented further based on Business, Indication, Synthesis, Type, End-User, and Geography.
  • By Business, the market is classified into captive API and merchant API. Amongst the two, the captive API segment is estimated to hold the highest market share during the forecast period.
  • By Indication, the market is classified as anti-infective, antiparasitics, and NSAIDS & anesthetics. Amongst all, the anti-infective segment is estimated to hold the highest market share during the forecast period.
  • By Synthesis, the market is classified as biotech and synthetic. Amongst the two, the biotech segment is estimated to hold the highest market share during the forecast period.
  • By Type, the market is classified as branded and generic. Amongst the two, the branded segment is estimated to hold the highest market share during the forecast period.
  • By End User, the market is classified as pet care hospitals, retail, and specialty pharmacies. Amongst all, the pet care hospitals segment is estimated to hold the highest market share during the forecast period.
  • By Geography, North America is projected to lead the market.

Recent Developments

  • INROADS partners with Zoetis for diversity opportunities in animal health. - 9th February 2021.
  • Olon S.p.A., a world-leading active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation.- 25th January 2019.

Key Topics Covered:

1 Report Description

1.1 Study Objectives

1.2 Market Definition

1.3 Currency

1.4 Years Considered

1.5 Language

1.6 Key Shareholders

2 Research Methodology

2.1 Research Process

2.2 Data Collection and Validation

2.3 Market Size Estimation

2.4 Assumptions of the Study

2.5 Limitations of the Study

3 Executive Summary

3.1 Introduction

3.2 Market Size and Segmentation

3.3 Market Outlook

4 Market Influencers

4.1 Drivers

4.1.1 Increasing Adoption of Pets

4.1.2 Increase in the Number of Animal Healthcare NGOs

4.2 Restraints

4.2.1 Risk Associated with Animal Health APIs

4.2.2 High Investment

4.3 Opportunities

4.3.1 Growing Research and Development for New Products

4.4 Challenges

4.4.1 Limited Awareness Towards Animal Health

4.5 Trends

5 Market Analysis

5.1 Regulatory Scenario

5.2 Porter’s Five Forces Analysis

5.3 Impact of COVID-19

5.4 Ansoff Matrix Analysis

6 Global Animal Health Active Pharmaceutical Ingredients Market, By Business

6.1 Introduction

6.2 Captive API

6.3 Merchant API

7 Global Animal Health Active Pharmaceutical Ingredients Market, By Indication

7.1 Introduction

7.2 Anti-infectives

7.3 Antiparasitic

7.4 NSAIDs & Anesthetics

8 Global Animal Health Active Pharmaceutical Ingredients Market, By Synthesis

8.1 Introduction

8.2 Biotech

8.3 Synthetic

9 Global Animal Health Active Pharmaceutical Ingredients Market, By Type

9.1 Introduction

9.2 Branded

9.3 Generic

10 Global Animal Health Active Pharmaceutical Ingredients Market, By End User

10.1 Introduction

10.2 Pet Care Hospitals

10.3 Retail

10.4 Specialty pharmacies

11 Global Animal Health Active Pharmaceutical Ingredients Market, By Geography

12 Competitive Landscape

12.1 Competitive Quadrant

12.2 Market Share Analysis

12.3 Strategic Initiatives

12.3.1 M&A and Investments

12.3.2 Partnerships and Collaborations

12.3.3 Product Developments and Improvements

13 Company Profiles

  • Blanver Farmoquimica E Farmaceutica S.A
  • Changzhou Yabang-Qh Pharmachem Co., Ltd
  • Eli Lilly & Co
  • Excel Industries Ltd
  • Glenmark Pharmaceutical Ltd.
  • Huvepharma
  • Indukern, S.A
  • Lonza Group AG
  • NGL Fine Chem Ltd
  • Ningxia Tairui Pharma CO. Ltd
  • Ofichem BV
  • Omkar Speciality Chemicals Limited
  • Ourofino Saude Animal
  • P&R SpA (Olon SpA)
  • Sanofi Winthrop Industrie (CEPiA)
  • Sequent Scientific Ltd
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
  • Shanghai Pharmtech Co. Ltd
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/mks5hy

View source version on businesswire.com:https://www.businesswire.com/news/home/20210823005403/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH VETERINARY

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 08/23/2021 09:48 AM/DISC: 08/23/2021 09:48 AM

http://www.businesswire.com/news/home/20210823005403/en